[1]
|
Tyndall, M.W., Nasio, J., Agoki, E., Malisa, W., Ronald, A.R., Ndinya-Achola, J.O., et al. (1995) Herpes Zoster as the Initial Presentation of Human Immunodeficiency Virus Type 1 Infection in Kenya. Clinical Infectious Diseases, 21, 1035-1037. https://doi.org/10.1093/clinids/21.4.1035
|
[2]
|
Wellar, T.H., Wetton, H.M. and Bell, E.J. (1958) The Etiological Agent of Varicella and Herpes Zoster: Isolation, Propagation and Cultural Characteristics in Vitro. Journal of Experimental Medicine, 108, 843-868. https://doi.org/10.1084/jem.108.6.843
|
[3]
|
Gnann, J.W. and Whitley, R.J. (2002) Herpes Zoster. New England Journal of Medicine, 347, 340-346. https://doi.org/10.1056/NEJMcp013211
|
[4]
|
Cohen, J.I. (2013) Clinical Practice: Herpes Zoster. New England Journal of Medicine, 369, 255e63.
|
[5]
|
Staikov, I., Neykov, N., Marinovic, B., Lipozencic, J. and Tsankov, N. (2014) Herpes Zoster as a Systemic Disease. Clinics in Dermatology, 32, 424-429. https://doi.org/10.1016/j.clindermatol.2013.11.010
|
[6]
|
Colebunders, R., Mann, J.M., Francis, H., Hila, K., Izaley, L., Iwaya, M., et al. (1988) Herpes Zoster in African Patients: A Clinical Predictor of Human Immunodeficiency Virus Infection. Journal of Infectious Diseases, 157, 314-318. https://doi.org/10.1093/infdis/157.2.314
|
[7]
|
Prescott, L.M., Harley, J.P. and Klein, D.A. (2002) Human Diseases Caused by Virus. Microbiology. 5th Edition, McGraw Hill, New York, 870-898.
|
[8]
|
Stevens, J.G. (1989) Human Herpes Viruses: A Consideration of the Latent State. Microbiological Reviews, 53, 318-332.
|
[9]
|
Cohen, J.I., Brunell, P.A., Straus, S.E. and Krause, P.R. (1999) Recent Advances in Varicella-Zoster Virus Infection. Annals of Internal Medicine, 130, 922-932. https://doi.org/10.7326/0003-4819-130-11-199906010-00017
|
[10]
|
Steiner, I., Kennedy, P.G. and Pachner, A.R. (2007) The Neurotropic Herpes Viruses: Herpes Simplex and Varicella Zoster. Lancet Neurology, 6, 1015-1028. https://doi.org/10.1016/S1474-4422(07)70267-3
|
[11]
|
Donahue, J.G., Chao, P.W., Manson, J.E. and Plat, R. (1995) The Incidence of Zoster. Archives of Internal Medicine, 155, 1605-1609. https://doi.org/10.1001/archinte.1995.00430150071008
|
[12]
|
Ragozzino, M.W., Melton 3rd, L.J., Kurland, L.T., Chu, C.P. and Perry, H.O. (1982) Population-Based Study of Herpes Zoster and Its Sequelae. Medicine, 61, 310-316. https://doi.org/10.1097/00005792-198209000-00003
|
[13]
|
Buchinder, S.P., Katz, M.H., Hessel, N.A., et al. (1992) Herpes Zoster and Human Immunodeficiency Virus Infection. The Journal of Infectious Diseases, 166, 1153-1156. https://doi.org/10.1093/infdis/166.5.1153
|
[14]
|
Naveen, K.N., Tophakane, R.S., Hanumanthayya, K., Pv, B. and Pai, V.V. (2011) A Study of HIV Seropositivity with Various Clinical Manifestation of Herpes Zoster among Patients from Karnataka, India. Dermatology Online Journal, 17, 3.
|
[15]
|
Dehne, K.L., Dhlakama, D.G., Richter, C., Mawadza, M., McClean, D. and Huss, R. (1992) Herpes Zoster as an Indicator of HIV Infection in Africa. Tropical Doctor, 22, 68e70. https://doi.org/10.1177/004947559202200207
|
[16]
|
Dahl, H., Marcoccia, J. and Linde, A. (1997) Antigen Detection: The Method of Choice in Comparison with Virus Isolation and Serology for Laboratory Diagnosis of Herpes Zoster in Human Immunodeficiency Virus-Infected Patient. Journal of Clinical Microbiology, 35, 345-349.
|
[17]
|
Gilden, D.H., Kleinschmidt-DeMaster, B.K., LaGuardia, J.J., Mahalingam, R. and Cohrs, R.J. (2000) Neurologic Complications of the Reactivation of Varicella-Zoster Virus. The New England Journal of Medicine, 342, 635-645. https://doi.org/10.1056/NEJM200003023420906
|
[18]
|
Harding, S.P., Lipton, J.R. and Wells, J.C. (1987) Natural History of Herpes Zoster Ophthalmicus: Predictors of Postherpetic Neuralgia and Ocular Involvement. British Journal of Ophthalmology, 71, 353-358. https://doi.org/10.1136/bjo.71.5.353
|
[19]
|
Shaikh, S. and Ta, C.N. (2002) Evaluation and Management of Herpes Zoster Ophthalmicus. American Family Physician, 66, 1723-1730.
|
[20]
|
Oxman, M.N., Levin, M.J., Johnson, G.R., et al. (2005) A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults. The New England Journal of Medicine, 352, 2271-2284. https://doi.org/10.1056/NEJMoa051016
|
[21]
|
Choo, P.W., Galil, K., Donahue, J.G., Walker, A.M., Spiegelman, D. and Platt, R. (1997) Risk Factors for Postherpetic Neuralgia. Archives of Internal Medicine, 157, 1217-1224. https://doi.org/10.1001/archinte.1997.00440320117011
|
[22]
|
Gnann, J.W. and Whitley, R.J. (1991) Natural History and Treatment of Varicella-Zoster Virus in High-Risk Populations. Journal of Hospital Infection, 18, 317-329.
|
[23]
|
Ormerod, L.D., Larkin, J.A., Margo, C.A., et al. (1998) Rapidly Progressive Herpetic Retinal Necrosis: A Blinding Disease Characteristic of Advanced AIDS. Clinical Infectious Diseases, 26, 34-45. https://doi.org/10.1086/516285
|
[24]
|
Thomas, S.L. and Hall, A.J. (2004) What Does Epidemiology Tell Us about Risk Factors for Herpes Zoster? The Lancet Infectious Diseases, 4, 26-33.
|
[25]
|
Forbes, H.J., Bhaskaran, K., Thomas, S.L., Smeeth, L., Clayton, T. and Langan, S.M. (2014) Quantification of Risk Factors for Herpes Zoster: Population Based Case-Control Study. BMJ, 348, g2911. https://doi.org/10.1136/bmj.g2911
|
[26]
|
Liu, B., Heywood, A.E., Reekie, J., Banks, E., Kaldor, J.M., MacIntyre, P., et al. (2015) Risk Factors for Herpes Zoster in a Large Cohort of Unvaccinated Older Adults: A Prospective Cohort Study. Epidemiology & Infection, 13, 2871-2881.
|
[27]
|
Onunu, A.N. and Uhunmwangho, A. (2004) Clinical Spectrum of Herpes Zoster in HIV-Infected versus Non-HIV Infected Patients in Benin City, Nigeria. West African Journal of Medicine, 23, 300-304.
|
[28]
|
Hira, S.K. (1996) Clinical Profile of HIV 1/2 Infection in Mumbai. Proceedings of the National Conference on HIV/AIDS Medicine, Pune, 23-24 November 1996, 35-39.
|
[29]
|
Friedman Kien, A.E., Lafleur, F.L., Gandler, E., et al. (1986) Herpes Zoster: A Possible Early Clinical Sign for Development of AIDS in High-Risk Individual. Journal of the American Academy of Dermatology, 14, 1023-1028. https://doi.org/10.1016/S0190-9622(86)70127-8
|
[30]
|
Melbye, M., Grossman, R.J., Goedert, J.J., et al. (1987) AIDS after Herpes Zoster. The Lancet, 316, 156-157.
|
[31]
|
Moss, A.R., Bacchett, P., Osmond, D., et al. (1988) Seropositivity for HIV and Development of AIDS or AIDS-Related Condition. Three Years Follow up of San Francisco Hospital Cohort. British Medical Journal, 296, 745-750. https://doi.org/10.1136/bmj.296.6624.745
|
[32]
|
Highet, A.S. and Kurtz, J. (1992) Viral Infections. In: Champion, R.H., Burton, J.L. and Ebling, F.J.G., Eds., Textbook of Dermatology, 5th Edition, Blackwell Scientific Publication, Oxford, 925.
|
[33]
|
Meer, S., Coleman, H., Altini, M. and Alexander, T. (2006) Mandibular osteomyelitis and Tooth Exfoliation Following Zoster-CMV Co-Infection. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 101, 70-75. https://doi.org/10.1016/j.tripleo.2005.06.022
|
[34]
|
Glesby, M.J., Hoover, D.R., Tan, T., et al. (2004) Herpes Zoster in Women with and at Risk for HIV: Data from the Women’s Interagency HIV Study. Journal of Acquired Immune Deficiency Syndromes, 37, 1604-1609. https://doi.org/10.1097/00126334-200412150-00013
|
[35]
|
Weinberg, A., Wiznia, A.A., LaFleur, B.J., Shah, S. and Levin, M.J. (2004) Varicella-Zoster Virus-Specific Cell-Mediated Immunity in HIV-Infected Children Receiving Highly Active Antiretroviral Therapy. The Journal of Infectious Diseases, 190, 267-270. https://doi.org/10.1086/422011
|
[36]
|
Levin, M.J., Anderson, J.P., Seage, G.R. and Williams, P.L. (2009) Short-Term and Long-Term Effects of Highly Active Antiretroviral Therapy on the Incidence of Herpes Zoster in HIV-Infected Children. Journal of Acquired Immune Deficiency Syndromes, 50, 182-191. https://doi.org/10.1097/QAI.0b013e31819550a4
|
[37]
|
French, M.A., Lenzo, N., John, M., Mallal, S.A., McKinnon, E.J., James, I.R., Price, P., Felxman, J.P. and Tay-Kearney, M.L. (2000) Immune Restoration Disease after the Treatment of Immunodeficient HIV-Infected Patients with Highly Active Antiretroviral Therapy. HIV Medicine, 1, 107-115. https://doi.org/10.1046/j.1468-1293.2000.00012.x
|
[38]
|
Espinosa, E., Peña-Jiménez, A., Ormsby, C.E., Vega-Barrientos, R. and Reyes-Terán, G. (2009) Later Onset of Herpes Zoster-Associated Immune Reconstitution Inflammatory Syndrome. HIV Medicine, 10, 454-457. https://doi.org/10.1111/j.1468-1293.2009.00700.x
|
[39]
|
Lawn, S.D., Bekker, L.G. and Miller, R.F. (2005) Immune Reconstitution Disease Associated with Mycobacterial Infections in HIV-Infected Individuals Receiving Antiretrovirals. The Lancet Infectious Diseases, 5, 361-373. https://doi.org/10.1016/S1473-3099(05)70140-7
|
[40]
|
Gebo, K.A., Kalyani, R., Moore, R.D. and Polydefkis, M.J. (2005) The Incidence of, Risk Factors for, and Sequelae of Herpes Zoster among HIV Patients in the Highly Active Antiretroviral Therapy Era. Journal of Acquired Immune Deficiency Syndromes, 40, 169-174. https://doi.org/10.1097/01.qai.0000178408.62675.b0
|
[41]
|
Lawn, S.D. and Wood, R. (2010) Immune Reconstitution Inflammatory Syndrome. The Lancet Infectious Diseases, 10, 833-834. https://doi.org/10.1016/S1473-3099(10)70280-2
|
[42]
|
Tsang, C.S. and Samaranayake, L.P. (2010) Immune Reconstitution Inflammatory Syndrome after Highly Active Antiretroviral Therapy: A Review. Oral Diseases, 16, 248-256. https://doi.org/10.1111/j.1601-0825.2009.01628.x
|
[43]
|
Rodgers, S. and Leslie, K.S. (2011) Skin Infection in HIV-Infected Individuals in the Era of HAART. Current Opinion in Infectious Diseases, 24, 124-129. https://doi.org/10.1097/QCO.0b013e328342cb31
|
[44]
|
Choi, W.R., et al. (2012) Herpes Zoster Immune Reconstitution Inflammatory Syndrome in a HIV-Infected Patient. Infection & Chemotherapy, 44, 391-394. https://doi.org/10.3947/ic.2012.44.5.391
|
[45]
|
Srikantiah, P., Walusimbi, M.N., Kayanja, H.K., Mayanja-Kizza, H., Mugerwa, R.D., Lin, R., Charlebois, E.D., Boom, W.H., Whalen, C.C. and Havlir, D.V. (2007) Early Virological Response of Zidovudine/Lamivudine/Abacavir for Patients Co-Infected with HIV and Tuberculosis in Uganda. AIDS, 21, 1972-1974. https://doi.org/10.1097/QAD.0b013e32823ecf6e
|
[46]
|
Shelburne, S.A., Visnegarwala, F., Darcourt, J., Graviss, E.A., Giordano, T.P., White, A.C. and Hamill, R.J. (2005) Incidence and Risk Factors for Immune Reconstitution Syndrome during Highly Active Antiretroviral Therapy. AIDS, 19, 399-406. https://doi.org/10.1097/01.aids.0000161769.06158.8a
|
[47]
|
Feller, L., Wood, N.H. and Lemmer, J. (2007) Herpes Zoster Infection as an Immune Reconstitution Inflammatory Syndrome in HIV-Seropositive Subjects: A Review. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 104, 455-460. https://doi.org/10.1016/j.tripleo.2007.02.001
|
[48]
|
Domingo, P., Torres, O.H., Ris, J. and Vazquez, G. (2001) Herpes Zoster as an Immune Reconstitution Disease after Initiation of Combination Antiretroviral Therapy in Patients with Human Immunodeficiency Virus Type-1 Infection. American Journal of Medicine, 110, 605-609. https://doi.org/10.1016/S0002-9343(01)00703-3
|
[49]
|
Naumann, G., Gass, J.D. and Font, R.L. (1968) Histopathology of Herpes Zoster Ophthalmicus. American Journal of Ophthalmology, 65, 533-541. https://doi.org/10.1016/0002-9394(68)93869-5
|
[50]
|
Goh, C.L. and Khoo, L. (1997) A Retrospective Study of the Clinical Presentation and Outcome of Herpes Zoster in a Tertiary Dermatology Outpatient Referral Clinic. International Journal of Dermatology, 36, 667-672. https://doi.org/10.1046/j.1365-4362.1997.00241.x
|
[51]
|
Cobo, M., Foulks, G.N., Liesegang, T., Lass, J., Sutphin, J., Wilhelmus, K., et al. (1987) Observations on the Natural History of Herpes Zoster Ophthalmicus. Current Eye Research, 6, 195-199. https://doi.org/10.3109/02713688709020090
|
[52]
|
Burgoon, C.F., Burgoon, J.S. and Baldridge, G.D. (1957) The Natural History of Herpes Zoster. JAMA, 174, 265. https://doi.org/10.1001/jama.1957.02980030041010
|
[53]
|
Sandor, E.V., Millman, A., Croxson, T.S. and Mildvan, D. (1986) Herpes Zoster Ophthalmicus in Patients at Risk for the Acquired Immune Deficiency Syndrome (AIDS). American Journal of Ophthalmology, 101, 153-155. https://doi.org/10.1016/0002-9394(86)90585-4
|
[54]
|
Baratz, K.H., Goins, K. and Cobo, M. (1988) Varicella-Zoster Viral Infections. In: Kaufman, H.E., Ed., The Cornea, Churchill Livingstone, New York, 279-298.
|
[55]
|
Arffa, R.C. (1997) Viral Diseases. In: Arffa, R.C. and Grayson, M., Eds., Grayson’s Diseases of the Cornea, 4th Edition, Mosby, St. Louis, 675-676.
|
[56]
|
Liesegang, T.J. (1985) Corneal Complications from Herpes Zoster Ophthalmicus. Ophthalmology, 92, 316-324. https://doi.org/10.1016/S0161-6420(85)34034-4
|
[57]
|
Jones, D.B. (1974) Herpes Zoster Ophthalmicus. In: Golden, B., Ed., Symposium on Ocular Inflammatory Disease, Thomas, Springfield, 198-200.
|
[58]
|
Womack, L.W. and Liesegang, T.J. (1983) Complications of Herpes Zoster Ophthalmicus. Archives of Ophthalmology, 101, 42-45. https://doi.org/10.1001/archopht.1983.01040010044004
|
[59]
|
Smith, J.B. and Fenske, N.A. (1995) Herpes Zoster and Internal Malignancy. The Southern Medical Journal, 88, 1089-1092. https://doi.org/10.1097/00007611-199511000-00001
|
[60]
|
Anderson, L.A., Landgren, O. and Engels, E.A. (2009) Common Community-Acquired Infections and Subsequent Risk of Chronic Lymphocytic Leukemia. British Journal of Haematology, 147, 444-449. https://doi.org/10.1111/j.1365-2141.2009.07849.x
|
[61]
|
Doody, M.M., Linet, M.S., Glass, A.G., Friedman, G.D., Pottern, L.M., Boice, J.D., et al. (1992) Leukemia, Lymphoma, and Multiple Myeloma Following Selected Medical Conditions. Cancer Causes Control, 3, 449-456. https://doi.org/10.1007/BF00051358
|
[62]
|
Ragozzino, M.W., Melton, L.J., Kurland, L.T., Chu, C.P. and Perry, H.O. (1982) Risk of Cancer after Herpes Zoster: A Population-Based Study. The New England Journal of Medicine, 307, 393-397. https://doi.org/10.1056/NEJM198208123070701
|
[63]
|
Fueyo, M.A. and Lookingbill, D.P. (1984) Herpes Zoster and Occult Malignancy. Journal of the American Academy of Dermatology, 11, 480-482. https://doi.org/10.1016/S0190-9622(84)70195-2
|
[64]
|
Buntinx, F., Wachana, R., Bartholomeeusen, S., Sweldens, K. and Geys, H. (2005) Is Herpes Zoster a Marker for Occult or Subsequent Malignancy? British Journal of General Practice, 55, 102-107.
|
[65]
|
Wang, Y.P., Liu, C.J., Hu, Y.W., Chen, T.J., Lin, Y.T. and Fung, C.P. (2012) Risk of Cancer among Patients with Herpes Zoster Infection: A Population-Based Study. CMAJ, 184, E804-E809. https://doi.org/10.1503/cmaj.120518
|
[66]
|
Iglar, K., Kopp, A. and Glazier, R.H. (2013) Herpes Zoster as a Marker of Underlying Malignancy. Open Medicine, 7, e68-e73.
|
[67]
|
Kurlan, J.G., Connelly, B.L. and Lucky, A.W. (2004) Herpes Zoster in the First Year of Life Following Postnatal Exposure to Varicella-Zoster Virus: Four Case Reports and a Review of Infantile Herpes Zoster. Archives of Dermatology, 140, 1268-1272. https://doi.org/10.1001/archderm.140.10.1268
|
[68]
|
Prabhu, S., Sripathi, H., Gupta, S. and Prabhu, M. (2009) Childhood Herpes Zoster: A Clustering of Ten Cases. Indian Journal of Dermatology, 54, 62-64. https://doi.org/10.4103/0019-5154.48991
|
[69]
|
Katakam, B.K., Kiran, G. and Kumar, U. (2016) A Prospective Study of Herpes Zoster in Children. Indian Journal of Dermatology, 61, 534-539. https://doi.org/10.4103/0019-5154.190121
|
[70]
|
Janniger, C.K., Eastern, J.S., Hopenthal, D.R., et al Herpes Zoster Updated March 6 2018, E-Medicine Article.
|
[71]
|
Bhushan, P., Sardana, K. and Mahajan, S. (2005) Dermatomal Vesicular Eruption in an Asymptomatic Infant. Dermatology Online Journal, 11, 26.
|
[72]
|
Solomon, A.R. (1988) New Diagnostic Tests for Herpes Simplex and Varicella Zoster Infection. Journal of the American Academy of Dermatology, 18, 218-221. https://doi.org/10.1016/S0190-9622(88)70032-8
|
[73]
|
Wu, C.L., Marsh, A. and Dworkin, R.H. (2000) The Role of Sympathetic Nerve Blocks in Herpes Zoster and Postherpetic Neuralgia. Pain, 87, 121-129. https://doi.org/10.1016/S0304-3959(00)00230-X
|
[74]
|
Dworkin, R.H., Perkins, F.M. and Nagasako, E.M. (2000) Prospects for the Prevention of Postherpetic Neuralgia in Herpes Zoster Patients. The Clinical Journal of Pain, 16, S90-S100. https://doi.org/10.1097/00002508-200006001-00016
|
[75]
|
Morton, P. and Thomson, A.N. (1989) Oral Acyclovir in the Treatment of Herpes Zoster in General Practice. New Zealand Medical Journal, 102, 93-95.
|
[76]
|
Wood, M.J., Kay, R., Dworkin, R.H., Soong, S.-J. and Whitley, R.J. (1996) Oral Acyclovir Therapy Accelerates Pain Resolution in Patients with Herpes Zoster: A Meta-Analysis of Placebo-Controlled Trials. Clinical Infectious Diseases, 22, 341-347. https://doi.org/10.1093/clinids/22.2.341
|
[77]
|
Beutner, K.R., Friedman, D.J., Forszpaniak, C., Andersen, P.L. and Wood, M.J. (1995) Valaciclovir Compared with Acyclovir for Improved Therapy for Herpes Zoster in Immunocompetent Adults. Antimicrobial Agents and Chemotherapy, 39, 1546-1553. https://doi.org/10.1128/AAC.39.7.1546
|
[78]
|
Tyring, S., Barbarash, R.A., Nahlik, J.E., et al. (1995) Famciclovir for the Treatment of Acute Herpes Zoster: Effects on Acute Disease and Postherpetic Neuralgia: A Randomized, Double-Blind, Placebo-Controlled Trial. Annals of Internal Medicine, 123, 89-96. https://doi.org/10.7326/0003-4819-123-2-199507150-00002
|
[79]
|
Tyring, S.K., Beutner, K.R., Tucker, B.A., Anderson, W.C. and Crooks, R.J. (2000) Antiviral Therapy for Herpes Zoster: Randomized, Controlled Clinical Trial of Valacyclovir and Famciclovir Therapy in Immunocompetent Patients 50 Years and Older. Archives of Family Medicine, 9, 863-869. https://doi.org/10.1001/archfami.9.9.863
|
[80]
|
Glesby, M.J., Moore, R.D. and Chaisson, R.E. (1995) Clinical Spectrum of Herpes Zoster in Adults Infected with Human Immunodeficiency Virus. Clinical Infectious Diseases, 21, 370-375. https://doi.org/10.1093/clinids/21.2.370
|
[81]
|
Gnann, J.W., Crumpacker, C.S., Lalezari, J.P., et al. (1998) Sorivudine versus Acyclovir for Treatment of Dermatomal Herpes Zoster in Human Immunodeficiency Virus-Infected Patients: Results from a Randomized, Controlled Clinical Trial. Antimicrobial Agents and Chemotherapy, 42, 1139-1145.
|
[82]
|
Safrin, S., Berger, T.G., Gilson, I., Wolfe, P.R. and Wofsy, C.B. (1991) Foscarnet Therapy in Five Patients with AIDS and Acyclovir-Resistant Varicella-Zoster Virus Infection. Annals of Internal Medicine, 115, 19-21. https://doi.org/10.7326/0003-4819-115-1-19
|
[83]
|
Whitley, R.J., Weiss, H., Gnann, J.W., et al. (1996) Acyclovir with and without Prednisone for the Treatment of Herpes Zoster: A Randomized, Placebo-Controlled Trial. Annals of Internal Medicine; 125, 376-383. https://doi.org/10.7326/0003-4819-125-5-199609010-00004
|
[84]
|
Bernstein, J.E., Korman, N.J., Bickers, D.R., Dahl, M.V. and Millikan, L.E. (1989) Topical Capsaicin Treatment of Chronic Postherpetic Neuralgia. Journal of the American Academy of Dermatology, 21, 265-270. https://doi.org/10.1016/S0190-9622(89)70171-7
|
[85]
|
Galer, B.S., Rowbotham, M.C., Perander, J. and Friedman, E. (1999) Topical Lidocaine Patch Relieves Postherpetic Neuralgia More Effectively than a Vehicle Topical Patch: Results of an Enriched Enrollment Study. Pain, 80, 533-538. https://doi.org/10.1016/S0304-3959(98)00244-9
|
[86]
|
Kanazi, G.E., Johnson, R.W. and Dworkin, R.H. (2000) Treatment of Postherpetic Neuralgia: An Update. Drugs, 59, 1113-1126. https://doi.org/10.2165/00003495-200059050-00007
|
[87]
|
Kotani, N., Kushikata, T., Hashimoto, H., et al. (2000) Intrathecal Methylprednisolone for Intractable Postherpetic Neuralgia. The New England Journal of Medicine, 343, 1514-1519. https://doi.org/10.1056/NEJM200011233432102
|
[88]
|
Davies, S.J., Harding, L.M. and Baranowski, A.P. (2002) A Novel Treatment of Post-Herpetic Neuralgia Using Peppermint Oil. The Clinical Journal of Pain, 18, 200-202. https://doi.org/10.1097/00002508-200205000-00011
|
[89]
|
Greenway, F.L., Frome, B.M., Engels, T.M. and McLellan, A. (2003) Temporary Relief of Post-Herpetic Neuralgia Pain with Topical Geranium Oil. The American Journal of Medicine, 115, 586-587. https://doi.org/10.1016/S0002-9343(03)00434-0
|
[90]
|
Sklar, S.H., Blue, W.T., Alexander, E.J. and Bodian, C.A. (1985) Herpes Zoster: The Treatment and Prevention of Neuralgia with Adenosine Monophosphate. JAMA, 253, 1427-1430. https://doi.org/10.1001/jama.1985.03350340079021
|
[91]
|
Friesen, K.J., Chateau, D., Falk, J., Alessi-Severini, S. and Bugden, S. (2017) Cost of Shingles: Population Based Burden of Disease Analysis of Herpes Zoster and Postherpetic Neuralgia. BMC Infectious Diseases, 17, 69. https://doi.org/10.1186/s12879-017-2185-3
|
[92]
|
Warren-Gash, C., Forbes, H. and Breuer, J. (2017) Varicella and Herpes Zoster Vaccine Development: Lessons Learned. Expert Review of Vaccines, 16, 1191-1201. https://doi.org/10.1080/14760584.2017.1394843
|
[93]
|
Sinéad, M.L., Smeeth, L., Margolis, D.J. and Thoma, S.L. (2013) Herpes Zoster Vaccine Effectiveness against Incident Herpes Zoster and Post-Herpetic Neuralgia in an Older US Population: A Cohort Study. PLOS Medicine, 10, e1001420. https://doi.org/10.1371/journal.pmed.1001420
|
[94]
|
Levin, M.J., Barber, D., Goldblatt, E., et al. (1998) Use of a Live Attenuated Varicella Vaccine to Boost Varicella-Specific Immune Responses in Seropositive People 55 Years of Age and Older: Duration of Booster Effect. The Journal of Infectious Diseases, 178, S109-S112. https://doi.org/10.1086/514264
|